EN DE
Watch Integer Holdings Corp for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Integer Holdings Corp (ITGR) fair value: what the stock is really worth

As of Nov 6, 2026: fair value (intrinsic value) of Integer Holdings Corp stock $56.98, price $127, that is 55.0% below the price, quality 54 out of 100. Rating: strongly overvalued. Calculated from audited financials with 22 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare US

IH Integer Holdings Corp logo Some data Nov 6, 2026

Integer Holdings Corp

ITGR · US
Solid, but very expensive

Our calculation puts a fair price 55% below what the stock costs today.

Healthy Growth (revenue 5y +11.5 %/yr in USD)
Generates free cash flow
Positive coverage
Quality 54/100
Thin margins · 5.7% net margin (TTM)
Moderate debt
Insiders sold $5.2M (6M)
Some data
Profit last quarter 61% below a year ago.
Fair value $56.98 · Strongly overvalued (−55.0%)
Trails peers (4/13)
Narrow moat 39/100 · thin data
Watch Integer Holdings Corp for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$144.36 $51.11 Fair Value $56.98 Aug 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 6, 2026.

How to read this chart

60‑month range $51.11 – $144.36 · fair‑value band $19.44 – $83.12 · the $126.56 price screens above the $56.98 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 6, 2026.

Follow Integer Holdings in your weekly email

Every Wednesday you see whether Integer Holdings is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally.

Show moreShow less

The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.

It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; implanted medical devices, implanted leads, procedure accessories, and external devices; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies.

In addition, the company offers rechargeable batteries and chargers; orthopedics, minimally invasive surgery, and general surgery devices; and portable medical devices, including patient monitoring, ventilators, portable defibrillators, portable ultrasound, and X-Ray machines.

Furthermore, the company provides medical technologies; supplies medical stamped components, and shallow and deep draw casings and assemblies; and epicardial pacing leads.

It serves multi-national original equipment manufacturers and affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, cardio and vascular, and advanced surgical and portable medical markets.

The company provides its products under the Greatbatch Medical and the Lake Region Medical brands. The company was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016.

Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

Stock analysis

Integer Holdings Corp (ITGR) currently trades at $126.56, while our model-based Fair Value estimate is $56.98, 55% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Multiples group reads highest at a median of $63.98 per share, and 0 of the 22 models we run sit above the $126.56 price.

Bear case: the Earnings-Based group reads lowest at $29.98, and 22 of the 22 models stay below the price. Data coverage for this calculation is medium.

Scenario range: $19.44 (bear) to $83.12 (bull), the price of $126.56 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 54/100 (solid quality), in the Healthcare sector.

Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.

Integer Holdings Corp reported revenue of $1.8B in FY2025 versus $1.2B in FY2021, a compound +10.9%/yr. Reported net income was $103M in FY2025, compounding +1.5%/yr from FY2021.

Key figures

Market cap $4.3B Mid · P/E ratio 42.5 · P/S ratio 2.37 · EPS (TTM) $2.98 · Net margin 5.7% · Return on equity 6.0% · Return on assets (EBIT) 5.5% (5-year average) · Operating margin 8.3%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 39 out of 100 (low confidence).

What moves the price

The last reported earnings sit well below what analysts expect (earnings in transition, for example after write-downs or an earnings dip); whether the stock is cheap or expensive hinges on the expected recovery actually arriving. Read the fair value with that caveat.

The share trades at its 52-week high and 90% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −15% fair-value upside, at −55%, ITGR screens richer than that median.

Fair Value models

Bear $19.44 Fair Value $56.98 Bull $83.12
Price $126.56 · Downside -55.0%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then ($2.55 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF $18.99 $58.34 $125.37 73
Owner Earnings n/a $6.80 >$27.20 73
EPV $19.44 $28.71 $36.89 73
All 22 models by family
DCF Models
FCF DCF $18.99 $58.34 $125.37 73
Owner Earnings n/a $6.80 >$27.20 73
5Y Revenue Exit $19.91 $59.39 $112.00 68
5Y EBITDA Exit $47.67 $114.64 $197.18 72
5Y P/E Exit $13.65 $46.93 $83.68 66
10Y Revenue Exit $17.27 $54.54 $109.39 61
10Y EBITDA Exit $37.54 $94.77 $179.25 64
10Y P/E Exit $15.01 $45.47 $86.16 59
Earnings-Based
Graham-Dodd $20.55 $83.76 $114.02 64
Lynch FV $20.99 $29.98 $38.98 61
PEG = 1.0 $20.99 $29.98 $38.98 57
EPV $19.44 $28.71 $36.89 73
Multiples
P/E Multiple $49.87 $66.50 $83.12 63
P/S Multiple $38.54 $51.39 $64.23 58
EV/EBIT $37.82 $63.98 $90.14 64
EV/EBITDA $64.32 $99.32 $134.31 66
EV/Revenue $15.35 $39.35 $63.36 50
Growth DCF
Growth DCF $19.19 $56.98 $121.05 72
Rev-Margin DCF $19.91 $58.59 $106.54 68
Economic Profit
Residual Income $40.75 $42.09 $45.59 71
ROIC Compounder $19.44 $28.71 $36.89 71
Growth Earnings
Growth-Adj P/E $37.43 $53.47 $69.51 67

Open the full fair value analysis →

Quality Score breakdown

Overall quality 54/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 31
How much profit the company makes from its sales and capital
Quality Growth 35
Are margins and returns getting better?
Cashflow 51
Do the profits arrive as real cash?
Financial strength 53
Debt, balance sheet and risk of trouble
Investment 71
Does it invest with discipline instead of growing at any price?
Low Volatility 80
How calm the share price moves, does not count
Price momentum 81
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 100
Distance to the 52-week high, does not count
New shares 90
Buys back shares or issues new ones?

Open the full quality analysis →

Insider trades

In the last 6 months, 2 officers or directors sold shares worth $5.2M and none bought.

  • SaleKirk K ThorChief Human Resources Officer31,540 shares at $126.24$4.0MSep 15, 2026
  • SaleAndrew SennPresident, Growth & Innovation9,408 shares at $126.30$1.2MSep 8, 2026
  • SaleTommy P ThomasVP, Corporate Controller2× since Nov 11, 2025: 1,709 shares, avg. $77.32$132,138Mar 13, 2026
  • BuyJohn A HarrisEVP, Global Ops and Manufactur1,650 shares at $70.00$115,500Nov 12, 2025

Plus 11 other filings such as grants, option exercises or tax withholding. They are not market purchases or sales.

Sales are often planned (taxes, diversification, 10b5-1 plans). Purchases with their own money are seen as the stronger sign. For information only: not part of the quality score or Fair Value.

Source: SEC Form 4, as of Nov 6, 2026. All filings at the SEC ↗

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 79/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+7.6%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+11.5%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+11.5%
Start year 2020 (pandemic). Over 10 years: +8.7% a year
Revenue growth 26 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+12.9%
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: adjusted.
+2.9%
Earnings growth per share plus dividend.
Earnings per share, growth per year+2.9%
Dividend (yield on the price)0.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−0.2% vs 9.5%, slowing
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.11% → 11%
Pace: the 5-year rate starts in 2020 (pandemic)

Growth Forecast

A lot of optimism in the price
The price assumes more growth than the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+24.6%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+3.9%
Yearly sales growth analysts expect, extended to five years.
After inflation (USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about +21.7% a year for the price and +1.5% for the forecasts.
Forecast 2026 (sales)−1.4%
Forecast 2027 (sales)+6.0%
Projected 2028 (sales)+5.5%
Projected 2029 (sales)+5.0%
Projected 2030 (sales)+4.5%

ITGR screens overvalued: fair value 55% below the price. Compare with Abbott Laboratories, →

Recent news

News mood ⓘNews mood, the average tone of recent news (96 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation. Positive
Recent news coverage is more positive than average.
Note from the team Oct 11, 2026
AI conclusion: The business benefits from established outsourcing relationships as a contract manufacturer for medical device makers but suffers from limited signals of a durable competitive moat along with low returns on equity and high leverage.
Main risk: A change in ownership could disrupt the established outsourcing relationships, affecting the stability of component supply contracts and resulting revenues.
Integer serves as a contract development and manufacturing partner for medical device makers, focusing on components rather than its own branded products. Our models currently see the shares as overvalued even as the company advances toward a potential ownership change. Will its established outsourcing relationships deliver steady results under new ownership, or will they face disruption from shifting priorities?
Join the discussion →

Compare Integer Holdings Corp with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Devices · 320 stocks

Beats the industry median on 4/13 measures
Overall it trails its industry peers.
Valuation
Quality Score 54 · Above median
Fair Value upside −55.0% · Below median
Profitability
Return on equity (12 months) 6.0% · Above median
Return on assets 3.0% · Above median
Net margin (12 months) 5.7% · Below median
Operating margin (12 months) 8.3% · Below median
Growth and dividend
Revenue growth (quarter YoY) −3.9% · Bottom 25%
Balance sheet
Debt / equity 0.68× · Highest 25%

Valuation Multiplesvs Medical Devices median · lower = cheaper

P/E (12 months) 42.5× · Priciest 25%
P/B 2.47× · book value is mostly goodwill ⓘGoodwill and other intangible assets are larger than the equity. The book value mainly reflects prices paid for past acquisitions, so we do not rank this P/B against the peer group.
P/S (12 months) 2.37× · Cheaper than median
Price / free cash flow (fiscal year) 41.1× · Pricier than median
EV/EBITDA 17.2× · Pricier than median
PEG 2.81× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 6
FUTURE (revenue growth)0 · sector 35
PAST (return on equity)24 · sector 17
HEALTH (low debt)66 · sector 98
DIVIDEND (yield)0 · sector 34

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Devices stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Stryker Corporation SYK $325.87 $358.46 +10% vs ITGR
Boston Scientific Corporation BSX $42.75 $47.03 +10% vs ITGR
DexCom, Inc DXCM $79.41 $87.35 +10% vs ITGR
Shenzhen Mindray Bio-Medical Electronics Co 300760 ¥184.15 ¥197.22 +7% vs ITGR
GE HealthCare Technologies Inc GEHC $82.38 $69.92 −15% vs ITGR
Edwards Lifesciences Corporation EW $102.14 $81.94 −20% vs ITGR
Siemens Healthineers AG SHL €44.66 €34.95 −22% vs ITGR
Abbott Laboratories, ABT $109.93 $75.28 −32% vs ITGR
Medtronic plc MDT $101.80 $65.61 −36% vs ITGR
Koninklijke Philips N.V PHIA €27.33 €15.23 −44% vs ITGR

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Evidence & backtest34 years, failed companies included Financial calculatorsDCF, Graham, PEG and more
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Integer Holdings Corp: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Integer Holdings Corp Fair Value". https://www.fairvalue-calculator.com/stock/ITGR

Frequently asked questions

Is Integer Holdings Corp (ITGR) overvalued or undervalued?
As of Nov 6, 2026, our model estimates a fair value of $56.98 versus a price of $126.56, about 55% lower (overvalued).
What is the fair value of ITGR?
Our model-based fair value for Integer Holdings Corp is $56.98 (as of Nov 6, 2026), built from audited fundamentals. The current price: $126.56.
What is the quality score of ITGR?
Integer Holdings Corp has a Quality Score of 54/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Integer Holdings Corp (ITGR)?
Our model-based price target is the fair value of $56.98 (as of Nov 6, 2026) from 22 valuation models. Cautious scenario $19.44, optimistic scenario $83.12. It is a calculation from audited fundamentals, not an analyst target.
What is the Integer Holdings Corp stock forecast for 2026?
Our models put fair value at $56.98, about 55% lower versus a price of $126.56 (overvalued). Cautious scenario $19.44, optimistic scenario $83.12. The calculation is refreshed regularly with new filings.
What is the revenue of Integer Holdings Corp (ITGR)?
Integer Holdings Corp reported trailing-twelve-month revenue of about $1.8B (latest available figure, as of Nov 6, 2026).
What growth is priced into Integer Holdings Corp (ITGR)?
For today's price to be fair in a discounted-cash-flow model, Integer Holdings Corp would have to grow free cash flow by +24.6 % per year for five years (discount rate 8.7 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +11.5 % per year. As of Nov 6, 2026.
What discount rate (WACC) does the fair value of ITGR use?
Our models discount Integer Holdings Corp at 8.7 %: a base by market capitalisation (mid), damped by beta 0.58, country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Integer Holdings Corp that is +24.6 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (8.7 %) and the same formula as our fair value.
How much growth has Integer Holdings Corp (ITGR) delivered so far?
Over the past 5 years revenue at Integer Holdings Corp grew +11.5 % a year. The price currently implies free-cash-flow growth of +24.6 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Integer Holdings Corp (ITGR) growing?
The median revenue growth in the sector is +6.2 % a year. That is the yardstick for the growth priced into Integer Holdings Corp (+24.6 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Integer Holdings Corp (ITGR)?
The free-cash-flow yield on the price is 2.43 %: that much free cash flow Integer Holdings Corp produces per unit of market value. When it exceeds the discount rate of our models (8.7 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Integer Holdings Corp (ITGR)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Integer Holdings Corp it is $56.98 per share (as of Nov 6, 2026), against a price of $126.56. It is the blended result of 22 valuation models in 6 families (DCF Models, Earnings-Based, Multiples, Growth DCF, Economic Profit, Growth Earnings).
Is Integer Holdings Corp stock overvalued or undervalued in 2026?
As of Nov 6, 2026, ITGR trades above its calculated fair value: price $126.56, fair value $56.98, a gap of about −55% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of ITGR?
No. The price is what the market pays today ($126.56); the fair value is what the company's own numbers justify ($56.98). For Integer Holdings Corp the two are $69.58 per share apart. That gap is exactly why we show both numbers side by side.
How much is Integer Holdings Corp worth?
The market values Integer Holdings Corp at about $4.3B (market capitalisation, as of Nov 6, 2026). Per share that is $126.56; our models calculate a fair value of $56.98 per share.
What do the bullish and bearish scenarios say about ITGR?
Our models span a range for Integer Holdings Corp: cautious scenario $19.44, base $56.98, optimistic $83.12 per share (as of Nov 6, 2026, price $126.56). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of ITGR?
Integer Holdings Corp trades at a price-to-earnings ratio of 42.5 (as of Nov 6, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $56.98 is built from several models across several years. Excluding one-off items of fiscal year 2025 it is 41.2 (reported for FY2025: 43.8). Median P/E at fiscal year-end, 9 fiscal years (2016 to 2025), earnings ex one-offs: 30.3. Other multiples: PEG 2.8, P/B 2.5, P/S 2.4, EV/EBITDA 17.2.
What is the PEG ratio of ITGR?
The PEG ratio of Integer Holdings Corp is 2.81 (P/E divided by earnings growth, as of Nov 6, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of Integer Holdings Corp (ITGR)?
Balance-sheet figures for Integer Holdings Corp (as of Nov 6, 2026): return on equity 6.0%, debt of 0.68 per unit of equity. They feed the Quality Score of 54/100, which measures business quality independently of the share price.
How far is ITGR from its 52-week high?
Integer Holdings Corp trades at $126.56, at its 52-week high of $126.75 and 90% above the low of $66.64 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of $56.98 is for.
Which stocks are comparable to Integer Holdings Corp?
From the same area (Healthcare) we also value Abbott Laboratories,, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Integer Holdings Corp stock attractive at the current price?
The data as of Nov 6, 2026: price $126.56, calculated fair value $56.98 (−55%), Quality Score 54/100, from 22 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of ITGR calculated?
We run Integer Holdings Corp through 22 models from 6 families: DCF Models, Earnings-Based, Multiples, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of $56.98 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0% above its aggregate fair value. Integer Holdings Corp itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Integer Holdings Corp (ITGR)?
The closing price on Nov 6, 2026 was $126.56. Our model-based fair value is $56.98, about 55% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Integer Holdings Corp right now?
The price sits above even our optimistic bull case ($83.12). The favourable scenario is already priced in. The model range is unusually wide ($19.44 to $83.12). The outcome hinges heavily on assumptions, so read the point estimate with caution. Solid but not exceptional quality (54/100) and above fair value, neither a clear bargain nor a standout compounder.
Where does the earnings growth of Integer Holdings Corp (ITGR) come from?
Earnings per share at Integer Holdings Corp grew +12.0 % a year from 2014 to 2025. Broken into its drivers: revenue per share +5.2 %, EBIT margin +1.9 %, tax rate +1.6 %, residual (interest, one-offs) +2.8 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.

Key figures of Integer Holdings Corp

How large is the market capitalisation of Integer Holdings Corp (ITGR)?
The market capitalisation of Integer Holdings Corp is $4.3B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Integer Holdings Corp (ITGR)?
The price-to-sales ratio of Integer Holdings Corp is 2.37 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Integer Holdings Corp (ITGR)?
Earnings per share at Integer Holdings Corp are $2.98 (price ÷ EPS = P/E 42.5). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Integer Holdings Corp (ITGR)?
The net margin of Integer Holdings Corp is 5.7% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Integer Holdings Corp (ITGR)?
The return on equity (ROE) of Integer Holdings Corp is 6.0% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Integer Holdings Corp (ITGR)?
On an EBIT basis the return on assets of Integer Holdings Corp is 5.5% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Integer Holdings Corp (ITGR)?
The operating margin of Integer Holdings Corp is 8.3% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Integer Holdings Corp (ITGR)?
Revenue at Integer Holdings Corp is growing −3.9% versus a year earlier (3y avg +11.5%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Integer Holdings Corp (ITGR)?
Earnings per share at Integer Holdings Corp are growing −61.3% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Integer Holdings Corp (ITGR) carry?
The net debt of Integer Holdings Corp is $1.4B (fiscal year 2025, ≈ 13.2 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Integer Holdings Corp in the live analysis

One click puts Integer Holdings Corp on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.